| Selected Balance Sheet Data |
Note 3. Selected Balance Sheet Data:
Inventories:
Inventories consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2026 |
|
2025 |
Raw materials |
|
$ |
94,898 |
|
$ |
89,080 |
Finished goods(1) |
|
|
111,890 |
|
|
106,188 |
Inventories |
|
$ |
206,788 |
|
$ |
195,268 |
(1) Finished goods inventory of $5,613 and $5,822 is included within Other long-term assets in the respective March 31, 2026 and June 30, 2025. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the Condensed Consolidated Balance Sheets dates.
Property and Equipment:
Property and equipment consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2026 |
|
2025 |
Land |
|
$ |
8,132 |
|
$ |
8,151 |
Buildings and improvements |
|
|
258,172 |
|
|
254,355 |
Machinery and equipment |
|
|
247,666 |
|
|
245,924 |
Construction in progress |
|
|
19,837 |
|
|
23,420 |
Property and equipment, cost |
|
|
533,807 |
|
|
531,850 |
Accumulated depreciation and amortization |
|
|
(300,817) |
|
|
(286,131) |
Property and equipment, net |
|
$ |
232,990 |
|
$ |
245,719 |
Intangible Assets:
Intangible assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2026 |
|
2025 |
Developed technology |
|
$ |
578,976 |
|
$ |
620,062 |
Tradenames |
|
|
94,340 |
|
|
152,648 |
Customer relationships |
|
|
210,119 |
|
|
212,800 |
Patents |
|
|
5,304 |
|
|
4,967 |
Other intangibles |
|
|
7,144 |
|
|
7,174 |
Definite-lived intangible assets |
|
|
895,883 |
|
|
997,651 |
Accumulated amortization |
|
|
(576,809) |
|
|
(632,052) |
Total intangible assets, net |
|
$ |
319,074 |
|
$ |
365,599 |
Changes to the carrying amount of net intangible assets for the period ended March 31, 2026 consist of (in thousands):
|
|
|
|
|
|
March 31, |
|
|
2026 |
Beginning balance |
|
$ |
365,599 |
Other additions |
|
|
338 |
Amortization expense |
|
|
(46,561) |
Currency translation |
|
|
(302) |
Ending balance |
|
$ |
319,074 |
Amortization expense related to intangible assets was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
Nine Months Ended |
|
|
March 31, |
|
March 31, |
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
Amortization expense |
|
$ |
15,534 |
|
$ |
19,158 |
|
$ |
46,561 |
|
$ |
58,267 |
The estimated future amortization expense for intangible assets as of March 31, 2026 is as follows (in thousands):
|
|
|
|
Remainder 2026 |
|
$ |
15,219 |
2027 |
|
|
58,681 |
2028 |
|
|
54,950 |
2029 |
|
|
40,870 |
2030 |
|
|
26,911 |
Thereafter |
|
|
122,443 |
Total |
|
$ |
319,074 |
Goodwill:
Changes to the carrying amount of goodwill for the period ended March 31, 2026 consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and |
|
|
|
|
Protein Sciences |
|
Spatial Biology |
|
Total |
June 30, 2025 |
|
$ |
426,776 |
|
$ |
554,159 |
|
$ |
980,935 |
Currency translation |
|
|
(2,593) |
|
|
(542) |
|
|
(3,135) |
March 31, 2026 |
|
$ |
424,183 |
|
$ |
553,617 |
|
$ |
977,800 |
We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a qualitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2025. No indicators of impairment were identified as part of our assessment.
Other Assets:
Other assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2026 |
|
2025 |
Equity method investment in Wilson Wolf |
|
$ |
231,028 |
|
$ |
235,983 |
Long-term inventory |
|
|
5,613 |
|
|
5,822 |
Investment in Spear Bio |
|
|
15,000 |
|
|
15,000 |
Notes receivable(1) |
|
|
8,119 |
|
|
2,184 |
Other |
|
|
4,611 |
|
|
24,927 |
Other assets |
|
$ |
264,371 |
|
$ |
283,916 |
| (1) |
Amounts relate to the divestiture of our businesses held-for-sale. |
|